已收盤 02-06 16:00:00 美东时间
+0.710
+0.96%
Hancock Whitney Corporation Files Initial Beneficial Ownership Statement for Chief Banking Officer Emory L. Mayfield Jr Hancock Whitney Corporation has filed an initial statement of beneficial ownership with the Securities and Exchange Commission. The filing lists Emory L. Mayfield Jr., Chief Bankin
02-04 05:38
今日重点评级关注:HC Wainwright & Co.:上调Tempest Therapeutics评级至"买入",目标价11美元;Guggenheim:维持Sportradar Gr"买入"评级,目标价从34美元升至35美元
01-23 19:46
今日重点评级关注:HC Wainwright & Co.:维持Adicet Bio"买入"评级,目标价从9美元升至50美元;韦德布什:维持Ardelyx, Inc."跑赢大市"评级,目标价从16美元升至19美元
01-22 15:09
DA Davidson analyst Gary Tenner maintains Hancock Whitney (NASDAQ:HWC) with a Buy and raises the price target from $77 to $79.
01-21 23:34
Hancock Whitney (NASDAQ:HWC) reported quarterly earnings of $1.49 per share which met the analyst consensus estimate. This is a 6.43 percent increase over earnings of $1.40 per share from the same period last year. The
01-21 05:03
今日重点评级关注:Needham:维持Vaxcyte"买入"评级,目标价从90美元升至110美元;Citizens: 维持LGI Homes"跑赢大市"评级,目标价从85美元升至95美元
01-08 18:33
Raymond James analyst Michael Rose maintains Hancock Whitney (NASDAQ:HWC) with a Strong Buy and raises the price target from $72 to $78.
01-07 21:56
今日重点评级关注:巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从9美元升至10美元;摩根大通:上调Recursion Pharmaceuticals评级至"超配",目标价从10美元升至11美元
2025-12-18 10:54
Barclays analyst Jared Shaw initiates coverage on Hancock Whitney (NASDAQ:HWC) with a Overweight rating and announces Price Target of $76.
2025-12-17 22:29
今日重点评级关注:Piper Sandler:维持MeiraGTx Hldgs"超配"评级,目标价从28美元升至30美元;RBC Capital:维持4D Molecular Therapeutics"跑赢大市"评级,目标价从26美元升至32美元
2025-11-12 11:43